Similar articles for PMID: 11199370

Year	Number of Results
1988	1
1992	3
1993	2
1994	3
1995	4
1996	7
1997	6
1998	20
1999	7
2000	12
2001	21
2002	19
2003	18
2004	13
2005	14
2006	8
2007	6
2008	7
2009	5
2010	7
2011	6
2012	6
2013	10
2014	9
2015	5
2016	4
2017	6
2018	10
2019	13
2020	14
2021	14
2022	19
2023	8
2024	0

1

In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.

Kinnman N, Andersson U, Hultcrantz R. Kinnman N, et al. Scand J Gastroenterol. 2000 Dec;35(12):1294-300. doi: 10.1080/003655200453656. Scand J Gastroenterol. 2000. PMID: 11199370

2

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E. Ben-Ari Z, et al. Cytokine. 2004 Jul 7;27(1):7-14. doi: 10.1016/j.cyto.2004.03.009. Cytokine. 2004. PMID: 15207246

3

TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.

Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos-Kudla B, Strzalka B, Fila A, Niedziolka D, Beniowski M, Ostrowska Z, Borgiel-Marek H, Kajdaniuk J, Sieminska L, Nowak M, Wilczok T, Pakula D, Filipczyk P. Marek B, et al. J Clin Pharm Ther. 2005 Jun;30(3):271-7. doi: 10.1111/j.1365-2710.2005.00644.x. J Clin Pharm Ther. 2005. PMID: 15896245

4

TGF-β isoforms inhibit hepatitis C virus propagation in transforming growth factor beta/SMAD protein signalling pathway dependent and independent manners.

Zou LL, Li JR, Li H, Tan JL, Wang MX, Liu NN, Gao RM, Yan HY, Wang XK, Dong B, Li YH, Peng ZG. Zou LL, et al. J Cell Mol Med. 2021 Apr;25(7):3498-3510. doi: 10.1111/jcmm.16432. Epub 2021 Mar 8. J Cell Mol Med. 2021. PMID: 33682288 Free PMC article.

5

Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.

Guido M, De Franceschi L, Olivari N, Leandro G, Felder M, Corrocher R, Rugge M, Pasino M, Lanza C, Capelli P, Fattovich G. Guido M, et al. Mod Pathol. 2006 Aug;19(8):1047-54. doi: 10.1038/modpathol.3800592. Epub 2006 May 12. Mod Pathol. 2006. PMID: 16699498 Free article.

6

Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.

Shirasaki T, Honda M, Shimakami T, Murai K, Shiomoto T, Okada H, Takabatake R, Tokumaru A, Sakai Y, Yamashita T, Lemon SM, Murakami S, Kaneko S. Shirasaki T, et al. Hepatology. 2014 Nov;60(5):1519-30. doi: 10.1002/hep.27277. Epub 2014 Oct 2. Hepatology. 2014. PMID: 24962339

7

Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.

Arias M, Lahme B, Van de Leur E, Gressner AM, Weiskirchen R. Arias M, et al. Cell Growth Differ. 2002 Jun;13(6):265-73. Cell Growth Differ. 2002. PMID: 12114216

8

Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.

Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. Janczewska-Kazek E, et al. World J Gastroenterol. 2006 Feb 14;12(6):961-5. doi: 10.3748/wjg.v12.i6.961. World J Gastroenterol. 2006. PMID: 16521228 Free PMC article.

9

Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patients.

Gomaa WM, Ibrahim MA, Shatat ME. Gomaa WM, et al. Saudi J Gastroenterol. 2014 Jan-Feb;20(1):59-65. doi: 10.4103/1319-3767.126324. Saudi J Gastroenterol. 2014. PMID: 24496160 Free PMC article.

10

Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1.

Corchero J, Martín-Partido G, Dallas SL, Fernández-Salguero PM. Corchero J, et al. Int J Exp Pathol. 2004 Oct;85(5):295-302. doi: 10.1111/j.0959-9673.2004.00397.x. Int J Exp Pathol. 2004. PMID: 15379962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

285 results

Results by year